Lomo, Ismael .
HRN: 25-28-94 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2025
CEFTAZIDIME 1GM (VIAL)
11/13/2025
11/20/2025
IV
2g
Q8h
CAP MR
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines